Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$94 Bn Vaccines Market Industry Trends and Global Forecasts, 2026-2035: 200+ Preventive Vaccines, Developed by Both Industry and Non-industry Players are Being Evaluated

globenewswire.com
EBS Mentioned as a key player in the vaccines market, which is expected to grow. No specific positive or negative news. NVAX Mentioned as a key player in the vaccines market, which is expected to grow. No specific positive or negative news. MRNA Mentioned as a key player in the vaccines market, which is expected to grow. No specific positive or negative news. PFE Mentioned as a key player in the vaccines market, which is expected to grow. No specific positive or negative news.

$94 Bn Vaccines Market Industry Trends and Global Forecasts, 2026-2035: 200+ Preventive Vaccines, Developed by Both Industry and Non-industry Players are Being Evaluated Dublin, May 27, 2026 (GLOBE NEWSWIRE) -- The "Vaccines Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Vaccine API, Targeted Patient Population, Type of Vaccines, Route of Administration and Key Geographical Region" report has been added to ResearchAndMarkets.com's offering.

The vaccines market is estimated to grow from USD 48 billion in the current year to USD 94 billion by 2030, at a CAGR of 11.9% during the forecast period, till 2030.

With the increasing threat of infectious diseases, there has been a rise in the need for vaccines worldwide. A vaccine is a type of biological formulation created using weakened or inactive microbes, along with their surface proteins and toxins. These vaccines offer active acquired immunity against specific diseases and allow the immune system to produce a robust response if a person encounters the same pathogen in the future.

Vaccination is now a critical means of lowering the risk of infectious diseases and decreasing global mortality rates. The global emergence of infectious diseases has highlighted the need for improved vaccines to mitigate disease risks. Recently, the World Health Organization published a report on disease outbreaks, revealing the rising number of people affected by Avian influenza A and Mpox.

Moreover, the European Centre for Disease Prevention and Control reported that approximately 4.5 million dengue cases had been documented worldwide, with about 4,000 fatalities confirmed. In addition, the World Health Organization announced approximately 64 new infectious diseases impacting individuals worldwide.

Further, approximately 2 million individuals affected by rotavirus are admitted to the hospital annually. In this context, numerous industry leaders, governmental bodies, and public health organizations have launched diverse immunization initiatives and concentrated on creating advanced vaccines. In was also recently reported that Biovac and Sanfoi established a collaboration for the manufacturing of inactivated polio vaccines in Africa. The aim of the collaboration is to increase the production of polio vaccines to satisfy the rising need for these vaccines in more than 40 African nations.

Additionally, French President Emmanuel Macron opted to collaborate with several African leaders in organizing a USD 1.1 billion initiative aimed at speeding up vaccine production in African nations. At present, various research projects have been launched by stakeholders to promote innovation in the healthcare sector and reduce the risk of transmitting infectious diseases. Due to the continuous need for vaccines and rising collaborations, the vaccine market is expected to expand at a consistent pace during the forecast period.

The key players active in this industry are Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur and Valneva. Currently, GlaxoSmithKline accounts to hold 21% of the overall vaccines market share in the current year. The highest share can be attributed to its extensive range of vaccines and GlaxoSmithKline's acceleration of research and development efforts in the vaccine sector.

VACCINES MARKET: KEY INSIGHTS

REASONS TO BUY THIS REPORT

Key Players in Vaccines Market

Vaccines Market

Type of Vaccine API

Targeted Patient Population

Type of Vaccines

Route of Administration

Key Geographical Region

ADDITIONAL BENEFITS

For more information about this report visit https://www.researchandmarkets.com/r/sqb2jh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachments